Publications by authors named "Rocco Merolla"

Claim this Profile
F
Forecasting the long-term impact of COVID-19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
Loreta A Kondili, Massimo Andreoni, Alessio Aghemo, Claudio Maria Mastroianni, Rocco Merolla

Liver Int· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study.
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Rocco Cosimo Damiano Merolla

PLoS One· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hepatitis C virus estimates of undiagnosed individuals in different Italian regions: a mathematical modelling approach by route of transmission and fibrosis progression with results up to January 2021.
Loreta A Kondili, Massimo Andreoni, Alessio Aghemo, Claudio Maria Mastroianni, Rocco Merolla

New Microbiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regions.
Loreta A Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Rocco Merolla

BMC Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for identification of advanced Parkinson's disease: the results of the Italian subgroup of OBSERVE-PD observational study.
Alessandro Stefani, Alessandro Tessitore, Nicola Tambasco, Giovanni Cossu, Maria Gabriella Ceravolo, Rocco Merolla

BMC Neurol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy.
Massimo Andreoni, Giovanni Di Perri, Marcello Persico, Andrea Marcellusi, Olivier Ethgen, Rocco Cosimo Damiano Merolla

Infect Dis Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression.
Loreta A Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Rocco Merolla

Epidemics· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports.
Renato Cutrera, Andrea Wolfler, Simonetta Picone, Giovanni A Rossi, Giuliana Gualberti, Rocco Merolla

Ital J Pediatr· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data.
Salvatore D'Angelo, Michele Gilio, Rita M D'Attino, Giuliana Gualberti, Rocco Merolla

Clin Exp Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study.
Pierluigi Macchioni, Carlo Salvarani, Niccolò Possemato, Marwin Gutierrez, Walter Grassi, Rocco Merolla

J Rheumatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease.
Alessandro Armuzzi, Gabriele Riegler, Federica Furfaro, Monia Baldoni, Francesco Costa, Rocco Merolla

Dig Liver Dis· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics.
Giovanni A Rossi, Maria Cristina Medici, Maria Cristina Arcangeletti, Marcello Lanari, Rocco Merolla

Eur J Pediatr· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004).
Maria Cristina Medici, Maria Cristina Arcangeletti, Giovanni A Rossi, Marcello Lanari, Rocco Merolla

New Microbiol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy.
Maria Cristina Medici, Maria Cristina Arcangeletti, Rocco Merolla, Carlo Chezzi,

Acta Biomed· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care centers in a central Italian city.
Maria Paola Ronchetti, Rocco Merolla, Saralee Bajaksouzian, Gianni Violo, Roberto Ronchetti

Clin Microbiol Infect· January 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis